The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Quadrivalent Flu Vaccine Market Research Report 2025
Synopsis
The global Quadrivalent Flu Vaccine market was valued at US$ 5284.8 million in 2023 and is anticipated to reach US$ 7697.8 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Quadrivalent Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quadrivalent Flu Vaccine.
Report Scope
The Quadrivalent Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quadrivalent Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quadrivalent Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Segment by Type
Intramuscular Injection
Nasal Spray
Intradermal Shot
Segment by Application
Hospital
Clinic
Public Health Agency
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quadrivalent Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Quadrivalent Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Quadrivalent Flu Vaccine market was valued at US$ 5284.8 million in 2023 and is anticipated to reach US$ 7697.8 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Quadrivalent Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quadrivalent Flu Vaccine.
Report Scope
The Quadrivalent Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quadrivalent Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quadrivalent Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Segment by Type
Intramuscular Injection
Nasal Spray
Intradermal Shot
Segment by Application
Hospital
Clinic
Public Health Agency
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quadrivalent Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Quadrivalent Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Quadrivalent Flu Vaccine Market Overview
1.1 Product Overview and Scope of Quadrivalent Flu Vaccine
1.2 Quadrivalent Flu Vaccine Segment by Type
1.2.1 Global Quadrivalent Flu Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Quadrivalent Flu Vaccine Segment by Application
1.3.1 Global Quadrivalent Flu Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Other
1.4 Global Quadrivalent Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Quadrivalent Flu Vaccine Revenue 2019-2030
1.4.2 Global Quadrivalent Flu Vaccine Sales 2019-2030
1.4.3 Global Quadrivalent Flu Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Quadrivalent Flu Vaccine Market Competition by Manufacturers
2.1 Global Quadrivalent Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Quadrivalent Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Quadrivalent Flu Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Quadrivalent Flu Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Quadrivalent Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Quadrivalent Flu Vaccine, Product Type & Application
2.7 Quadrivalent Flu Vaccine Market Competitive Situation and Trends
2.7.1 Quadrivalent Flu Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Quadrivalent Flu Vaccine Players Market Share by Revenue
2.7.3 Global Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Quadrivalent Flu Vaccine Retrospective Market Scenario by Region
3.1 Global Quadrivalent Flu Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Quadrivalent Flu Vaccine Global Quadrivalent Flu Vaccine Sales by Region: 2019-2030
3.2.1 Global Quadrivalent Flu Vaccine Sales by Region: 2019-2024
3.2.2 Global Quadrivalent Flu Vaccine Sales by Region: 2025-2030
3.3 Global Quadrivalent Flu Vaccine Global Quadrivalent Flu Vaccine Revenue by Region: 2019-2030
3.3.1 Global Quadrivalent Flu Vaccine Revenue by Region: 2019-2024
3.3.2 Global Quadrivalent Flu Vaccine Revenue by Region: 2025-2030
3.4 North America Quadrivalent Flu Vaccine Market Facts & Figures by Country
3.4.1 North America Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Quadrivalent Flu Vaccine Sales by Country (2019-2030)
3.4.3 North America Quadrivalent Flu Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Quadrivalent Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Quadrivalent Flu Vaccine Sales by Country (2019-2030)
3.5.3 Europe Quadrivalent Flu Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Quadrivalent Flu Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Quadrivalent Flu Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Quadrivalent Flu Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Quadrivalent Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Quadrivalent Flu Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Quadrivalent Flu Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Quadrivalent Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Quadrivalent Flu Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Quadrivalent Flu Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Quadrivalent Flu Vaccine Sales by Type (2019-2030)
4.1.1 Global Quadrivalent Flu Vaccine Sales by Type (2019-2024)
4.1.2 Global Quadrivalent Flu Vaccine Sales by Type (2025-2030)
4.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Quadrivalent Flu Vaccine Revenue by Type (2019-2030)
4.2.1 Global Quadrivalent Flu Vaccine Revenue by Type (2019-2024)
4.2.2 Global Quadrivalent Flu Vaccine Revenue by Type (2025-2030)
4.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Quadrivalent Flu Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Quadrivalent Flu Vaccine Sales by Application (2019-2030)
5.1.1 Global Quadrivalent Flu Vaccine Sales by Application (2019-2024)
5.1.2 Global Quadrivalent Flu Vaccine Sales by Application (2025-2030)
5.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Quadrivalent Flu Vaccine Revenue by Application (2019-2030)
5.2.1 Global Quadrivalent Flu Vaccine Revenue by Application (2019-2024)
5.2.2 Global Quadrivalent Flu Vaccine Revenue by Application (2025-2030)
5.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Quadrivalent Flu Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Quadrivalent Flu Vaccine Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Quadrivalent Flu Vaccine Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Quadrivalent Flu Vaccine Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Quadrivalent Flu Vaccine Industry Chain Analysis
7.2 Quadrivalent Flu Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Quadrivalent Flu Vaccine Production Mode & Process
7.4 Quadrivalent Flu Vaccine Sales and Marketing
7.4.1 Quadrivalent Flu Vaccine Sales Channels
7.4.2 Quadrivalent Flu Vaccine Distributors
7.5 Quadrivalent Flu Vaccine Customers
8 Quadrivalent Flu Vaccine Market Dynamics
8.1 Quadrivalent Flu Vaccine Industry Trends
8.2 Quadrivalent Flu Vaccine Market Drivers
8.3 Quadrivalent Flu Vaccine Market Challenges
8.4 Quadrivalent Flu Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
